Category: Life Sciences
Global Life Sciences
-
Global Lithium-Ion Battery Rechargeable Hearing Aids Market Research Report 2024(Status and Outlook)
... to replace the battery and directly to charge. The Global Lithium-Ion Battery Rechargeable Hearing Aids Market Size was estimated at USD 3966.57 million in 2023 and is projected to reach USD 5755.26 million by 2029, ... Read More
-
Global Mammalian Cell Culture Service Market Research Report 2024(Status and Outlook)
... development in the life sciences. They allow for the study of complex biological processes in a controlled and reproducible manner. The Global Mammalian Cell Culture Service Market Size was estimated at USD 3902.17 million in ... Read More
-
Photoacoustic Imaging Market by Product (Imaging System, Transducer, Software, Accessories), Technology (Microscopy, Tomography), Type (Preclinical, Clinical), Application (Oncology, Neuro), End User (Hospitals, Academia) & Region Global Forecast to 2029
... projected to reach USD 105 million by 2029 from USD 80 million in 2024, at a CAGR of 5.5% during the forecast period of 2024 to 2029. The market is experiencing an upward trend driven ... Read More
-
Soldier Systems
... at a CAGR of 5.0% over the analysis period 2023-2030. Personal Protection, one of the segments analyzed in the report, is expected to record a 3.3% CAGR and reach US$3.5 Billion by the end of ... Read More
-
mRNA Platform
... at a CAGR of -3.1% over the analysis period 2023-2030. Covid-19 Vaccine, one of the segments analyzed in the report, is expected to record a -6.1% CAGR and reach US$96.5 Billion by the end of ... Read More
-
Syringes
... of 6.9% over the analysis period 2023-2030. Prefilled Syringes, one of the segments analyzed in the report, is expected to record a 8.4% CAGR and reach US$10.6 Billion by the end of the analysis period. ... Read More
-
Batteries in Medical Equipment and Devices
... the year 2023, is expected to reach US$4.5 Billion by 2030, growing at a CAGR of 6.7% over the analysis period 2023-2030. Lithium Batteries, one of the segments analyzed in the report, is expected to ... Read More
-
Biotechnology Reagents
... at a CAGR of 4.5% over the analysis period 2023-2030. Chromatography Technology, one of the segments analyzed in the report, is expected to record a 3.5% CAGR and reach US$40.6 Billion by the end of ... Read More
-
ENT and Bronchoscopy Devices
... reach US$32.2 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2023-2030. Endoscopes, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$7.8 ... Read More
-
Color Cosmetics
... at a CAGR of 4.6% over the analysis period 2023-2030. Color Cosmetics for Prestige Product Market, one of the segments analyzed in the report, is expected to record a 5.1% CAGR and reach US$73.0 Billion ... Read More
-
Acute Coronary Syndrome
... by 2030, growing at a CAGR of 10.5% over the analysis period 2023-2030. The U.S. Market is Estimated at US$2.3 Billion While China is Forecast to Grow at 16.4% CAGR The Acute Coronary Syndrome market ... Read More
-
Anti-Counterfeit Packaging
... at a CAGR of 9.3% over the analysis period 2023-2030. Mass Encoding Technology, one of the segments analyzed in the report, is expected to record a 9.7% CAGR and reach US$109.6 Billion by the end ... Read More
-
Enteral Feeding Devices
... by 2030, growing at a CAGR of 5.7% over the analysis period 2023-2030. Enteral Feeding Tubes, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$3.5 Billion ... Read More
-
Intracranial Stents
... at a CAGR of 13.0% over the analysis period 2023-2030. Self-Expanding Stents, one of the segments analyzed in the report, is expected to record a 14.1% CAGR and reach US$594.0 Million by the end of ... Read More
-
Industrial Enzymes
... at a CAGR of 4.4% over the analysis period 2023-2030. Carbohydrases, one of the segments analyzed in the report, is expected to record a 4.3% CAGR and reach US$3.6 Billion by the end of the ... Read More
-
Intraocular Lenses
... at a CAGR of 5.7% over the analysis period 2023-2030. Standard Intraocular Lenses, one of the segments analyzed in the report, is expected to record a 4.9% CAGR and reach US$3.6 Billion by the end ... Read More
-
Blood Pressure Monitoring and Measurement Instruments
... the year 2023, is expected to reach US$4.3 Billion by 2030, growing at a CAGR of 9.4% over the analysis period 2023-2030. Sphygmomanometers, one of the segments analyzed in the report, is expected to record ... Read More
-
Medical Laser Systems
... by 2030, growing at a CAGR of 9.8% over the analysis period 2023-2030. Diode Laser Systems, one of the segments analyzed in the report, is expected to record a 10.3% CAGR and reach US$1.6 Billion ... Read More
-
Pulse Oximeters
... at a CAGR of 3.7% over the analysis period 2023-2030. Handheld Pulse Oximeters, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$1.5 Billion by the end ... Read More
-
Anti-Hypertensive Drugs
... at a CAGR of 2.8% over the analysis period 2023-2030. Calcium Channel Blockers, one of the segments analyzed in the report, is expected to record a 3.2% CAGR and reach US$7.2 Billion by the end ... Read More
-
Migraine Drugs
... at a CAGR of 16.1% over the analysis period 2023-2030. Acute Treatment, one of the segments analyzed in the report, is expected to record a 16.7% CAGR and reach US$7.2 Billion by the end of ... Read More
-
Carbon Dioxide (CO2) Monitors
... reach US$815.5 Million by 2030, growing at a CAGR of 8.8% over the analysis period 2023-2030. End-Tidal Carbon Dioxide (EtCO2) Monitors, one of the segments analyzed in the report, is expected to record a 9.2% ... Read More
-
Stem Cells
... at a CAGR of 7.4% over the analysis period 2023-2030. Adult Stem Cells, one of the segments analyzed in the report, is expected to record a 7.2% CAGR and reach US$17.8 Billion by the end ... Read More
-
Urodynamics Equipment and Disposables
... reach US$325.5 Million by 2030, growing at a CAGR of 5.4% over the analysis period 2023-2030. Uroflowmetry Equipment, one of the segments analyzed in the report, is expected to record a 6.3% CAGR and reach ... Read More
-
Attention Deficit Hyperactivity Disorder (ADHD) Therapeutics
... the year 2023, is expected to reach US$57.7 Billion by 2030, growing at a CAGR of 7.6% over the analysis period 2023-2030. Stimulant Drugs, one of the segments analyzed in the report, is expected to ... Read More
Research Assistance
